Delivery Order SPE2DB24D6039-SPE2DB25FLENK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,552.67 delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhaler (12 grams) on September 10, 2025, with completion expected by September 11, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's existing pharmaceutical supply agreements with the federal government. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.52 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12 grams) under a firm fixed-price contract with an ultimate completion date of August 26, 2025. This non-set-aside award was competitively procured and represents a single delivery order transaction under the company's broader pharmaceutical supply relationships with the federal government. The place of performance is listed as...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams) valued at $19,776.09. This firm fixed-price delivery order is set to be completed by September 10, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a delivery order valued at $5,586.85 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12-gram units). This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12-gram units) with a contract ceiling value of $6,737.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLENKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,195.18 to supply Advair HFA 115-21 mcg inhalers (12 gm) with a completion date of September 11, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning itself as a critical vendor for pharmaceutical procurement within the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/10/25 |